ClinicalTrials.Veeva

Menu

Acute Intestinal Necrosis- the Preoperative Diagnostic Approach (AIN)

A

Aalborg University Hospital

Status

Completed

Conditions

Acute Mesenteric Ischemia

Treatments

Diagnostic Test: Blood sample analysis

Study type

Observational

Funder types

Other

Identifiers

NCT05665946
AalborgAIN

Details and patient eligibility

About

To investigate a number of blood based parameters in patients with intestinal ischaemia compared to patients with other acute abdominal diseases.

Full description

Intestinal ischemia is a life-threatening condition defined by interrupted blood supply to the intestinal tissue. Primary and secondary ischemia is obstruction of blood-supply due to vascular and extra-vascular pathology, respectively.

Early diagnosis and treatment are critical to save the ischemic bowel. Clinical findings of secondary intestinal ischaemia are related to the underlying cause e.g. vomiting and palpable hernia. Abdominal computed tomography (CT) can effectively visualize the causes. In contrast, the diagnosis of primary intestinal ischemia is often delayed due to the absence of specific clinical findings. Primary intestinal ischemia is visualized with CT ateriography, revealing mesentery arterial obstruction. However, in the acute setting a non-arterial phase CT is often performed but the findings are unspecific in the early stages and the pattern of findings which could indicate primary ischemia are not well understood. In primary and secondary ischemia, standard blood-based parameters are inconsistently elevated and highly unspecific. Newer blood-based parameters such as D-lactate has been proposed as ischaemic markers. D-lactate is produced by bacteria in the bowel lumen and translocation through a damaged bowel wall makes it a potential marker of intestinal ischemia.

A case-control-study of all acute admitted patients with abdominal pain in Aalborg, Denmark in the mentioned time range. The sensitivity and specificity of potiential biomarkers in a blood sample at time of admission as a marker of intestinal ischaemia will be examined.

Enrollment

2,958 patients

Sex

All

Ages

18 to 120 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Referred to The Department of Gastrointestinal Surgery, Aalborg University Hospital.

Exclusion criteria

  • Children

Trial design

2,958 participants in 2 patient groups

AIN patients
Description:
Surgical verified AIN patients. A blood sample is drawn just after inclusion and stored for later analysis.
Treatment:
Diagnostic Test: Blood sample analysis
Controls.
Description:
Non-AIN patients. A blood sample is drawn just after inclusion and stored for later analysis.
Treatment:
Diagnostic Test: Blood sample analysis

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems